Gastroenterology
The evolutionary history of the human microbiota could help to understand the role of present-day gut microbes in health and disease.
Targeted manipulation to promote the microbial diversity could be an important strategy to treat long COVID-19 and speed up recovery.
Gut bacteria from people in industrialized countries exchange genes at much higher rates than bacteria from people living in non-industrialized societies.
The microbial communities inhabiting the gut have been shown to change in ways that influence the development of disease through blood metabolites.
A targeted decontamination could be a strategy to control the spreading of carbapenem-resistance plasmids both amoung patients and within patients.
Gut microbes contribute to symptoms associated with neurological conditions. New microbe-inspired therapies could be develop to treat such conditions.
Microbial transplants could be used as a non-invasive and safe strategy to manipulate the gut microbiota, which has been linked to HIV infection.
Common gut fungi called Debaryomyces hansenii can influence the severity of Crohn’s disease and other inflammatory bowel diseases.
The alterations in gut microbial composition could play a role in the gastrointestinal complications associated with Parkinson’s disease.
Intestinal infections ‘train’ the gut microbiota to produce taurine, which promotes the growth of protective gut bacteria.
